Cloud-Based Drug Discovery Platforms

A Global Strategic Business Report

MCP11099



QUESTIONNAIRE EXECUTIVES DATA ROOM
  

HIGHLIGHTS & REPORT INDEX

Global Cloud-Based Drug Discovery Platforms Market to Reach US$6.8 Billion by 2030

The global market for Cloud-Based Drug Discovery Platforms estimated at US$2.6 Billion in the year 2023, is expected to reach US$6.8 Billion by 2030, growing at a CAGR of 14.3% over the analysis period 2023-2030. Pharmaceutical Vendors End-Use, one of the segments analyzed in the report, is expected to record a 15.2% CAGR and reach US$3.0 Billion by the end of the analysis period. Growth in the Biotech Vendors End-Use segment is estimated at 12.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$937.2 Million While China is Forecast to Grow at 15.9% CAGR

The Cloud-Based Drug Discovery Platforms market in the U.S. is estimated at US$937.2 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$745.9 Million by the year 2030 trailing a CAGR of 15.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 12.9% and 13.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 14.2% CAGR.

Global Cloud-Based Drug Discovery Platforms Market - Key Trends and Drivers Summarized

Are Cloud-Based Drug Discovery Platforms the Key to Faster Breakthroughs in Medicine?

Cloud-based drug discovery platforms are rapidly transforming the pharmaceutical industry, providing unprecedented opportunities for faster, more efficient, and cost-effective drug development. Traditionally, drug discovery has been an arduous process requiring massive investments in physical infrastructure, sophisticated equipment, and human resources. The shift toward cloud technology, however, is reshaping this landscape by allowing pharmaceutical companies and research institutions to harness the power of computational biology, artificial intelligence, and big data analytics without needing to invest in extensive on-premise infrastructure. The global push for innovation in the face of rising healthcare challenges, such as emerging diseases and antibiotic resistance, is a major driver for this transition. Cloud-based platforms enable collaborative research across geographies, facilitating the exchange of data, knowledge, and tools in real time. Moreover, the increasing complexity of biological data from genomics, proteomics, and other sources has made traditional data processing methods inefficient. Cloud platforms provide the computational power needed to analyze these large datasets, accelerating the identification of potential drug candidates and expediting the entire drug discovery process.

How Are Cloud-Based Platforms Revolutionizing Drug Discovery?

Cloud-based drug discovery platforms offer numerous advantages over traditional methods, primarily through the integration of vast amounts of data, computing resources, and artificial intelligence tools. One of the most significant impacts of these platforms is the ability to analyze massive datasets from genomics, chemical libraries, clinical trials, and electronic health records in a fraction of the time it would take using conventional methods. Cloud platforms facilitate high-throughput screening, allowing researchers to evaluate the interactions between thousands of compounds and biological targets simultaneously. This reduces the time it takes to identify promising candidates for further investigation. Another critical aspect of cloud-based platforms is their ability to foster collaboration between researchers, pharmaceutical companies, and academic institutions, regardless of their geographic location. This democratization of access to cutting-edge tools and resources is breaking down barriers to innovation. Furthermore, cloud platforms are particularly well-suited for incorporating AI and machine learning algorithms that predict the efficacy, toxicity, and side effects of drug candidates. This not only improves the likelihood of success in the early stages of drug development but also reduces the need for costly and time-consuming in vitro and in vivo testing.

How Does Technology Enable the Success of Cloud-Based Drug Discovery?

The core technological advancements driving cloud-based drug discovery platforms are the integration of artificial intelligence, machine learning, and big data analytics. These technologies enable pharmaceutical researchers to sift through massive datasets, identifying patterns and relationships that would otherwise be difficult or impossible to discern using manual or traditional computational methods. AI and machine learning models are being trained on datasets comprising millions of known chemical structures, biological interactions, and clinical outcomes, enabling them to predict which new compounds are most likely to succeed in becoming viable drug candidates. Another key technological driver is the use of quantum computing, which is beginning to make inroads into the drug discovery process. Quantum computers can simulate complex molecular structures and predict how drugs will interact with specific proteins or genetic markers with greater precision than traditional computers. Cloud-based platforms also leverage secure APIs to integrate with laboratory information management systems (LIMS), patient databases, and third-party tools, creating a seamless workflow from initial research to clinical trials. Furthermore, the scalability of cloud platforms allows researchers to quickly expand their computing power when needed, without the prohibitive costs associated with purchasing additional hardware. This flexibility is crucial for projects where computational needs can vary dramatically depending on the stage of discovery.

What Are the Key Growth Drivers in the Cloud-Based Drug Discovery Platforms Market?

The growth in the cloud-based drug discovery platform market is driven by several factors, each underscoring the changing landscape of pharmaceutical research and development. First, the increasing complexity and volume of biological data have outstripped the capabilities of traditional data processing methods. Cloud platforms provide the necessary computational power to process and analyze vast datasets quickly and efficiently, making it possible to identify drug candidates in a fraction of the time. The adoption of AI and machine learning technologies is another key driver, as these tools allow researchers to make more informed predictions about drug efficacy, safety, and side effects at earlier stages of the discovery process. This reduces both the time and cost associated with drug development, making it particularly attractive to pharmaceutical companies looking to streamline operations. Additionally, the trend toward personalized medicine is propelling the use of cloud platforms, as these systems can integrate genomic and proteomic data to identify treatments tailored to individual patients. The collaborative nature of cloud platforms is also a critical growth factor. By enabling real-time data sharing between researchers, pharmaceutical companies, and academic institutions, cloud-based platforms accelerate innovation and reduce duplication of efforts. Furthermore, the financial flexibility offered by cloud platforms, which operate on a pay-as-you-go model, allows even smaller companies and startups to access high-end computational resources, leveling the playing field in the competitive drug discovery market.

SCOPE OF STUDY

The report analyzes the Cloud-Based Drug Discovery Platforms market by the following Segments, and Geographic Regions/Countries:

Segments:
Service Type (PaaS (Platform as a Service), SaaS (Software as a Service), IaaS (Infrastructure as a Service)); End-Use (Pharmaceutical Vendors End-Use, Biotech Vendors End-Use, Contract Research Organizations End-Use, Other End-Uses).

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World..

SELECT PLAYERS

Accenture PLC; Acelot, Inc.; Cloud Pharmaceuticals, Inc.; Dassault Systemes; IBM Corporation; SAS Institute, Inc.; Tata Consultancy Services Ltd.; WuXi AppTec

TABLE OF CONTENTS

1. MARKET OVERVIEW
Cloud-based Drug Discovery Platforms: Revolutionizing Pharmaceutical Research
Drug Discovery Evolves with Cloud-Based Platforms
Economic Frontiers: Trends, Trials & Transformations
EXHIBIT : In a World Torn by Geopolitical Instability & War, Steadfastness of Global GDP Becomes Increasingly Unpredictable Given the Many Direct and Indirect Economic Repercussions: World Economic Growth Projections (Real Gross Domestic Product (GDP), Annual % Change) for the Years 2022 Through 2025
EXHIBIT: All Eyes on Global Inflation, the Main Risk Factor in Global Markets: Global Headline Inflation Rates (In %) for the Years 2019 through 2025
EXHIBIT: With Oil Prices Influencing the Rate of inflation, it Remains the Most Watched Commodity in Global Markets: Global Average Annual Brent Crude Oil Price (In US$ Per Barrel) for Years 2019 through 2025
Competitive Scenario
Existing Players & Pioneering Start-Ups Shaping Dynamics of Cloud Based Drug Discovery Platform Market
Cloud-Based Drug Discovery Platforms – Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for 59 Players Worldwide in 2024 (E)
Global Market Overview and Prospects
Global Cloud-Based Drug Discovery Platforms Market Discovers New Growth Horizons
Pharmaceutical Companies: Leading End-User Segment of Global Market
North America Rules Global Cloud-Based Drug Discovery Platforms Market
Europe to Exhibit Consistent Growth
Asia-Pacific Region to Enjoy Healthy Growth
Global Cloud Based Drug Discovery Platform Market on a High with Pulsating Drivers
Rising Costs & Complexity of Drug Discovery Process
Massive Investments in Drug Discovery R&D
Intriguing Perks of Cloud-based Platforms
Advances Favoring Cloud-Based Drug Discovery Platforms
Influx of Advanced Solutions
Recent Market Activity
Influencer/Product/Technology Insights
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Cloud-Based Drug Discovery Platforms: The Pill of Choice to Expedite Drug Discovery
EXHIBIT: Increase in R&D Costs of a New Approved Drug (1980s-2020s)
Increasing R&D Investments and the Rising Demand for Cloud-Based Drug Discovery Platforms
EXHIBIT: Global Pharmaceutical R&D Spending in US$ Billion (2018-2026P)
The Role of Cloud-Based Platforms in Reducing Drug Costs
EXHIBIT: Global Prescription Drug Sales (In US$ Trillion) for the Years 2019, 2020, 2021 & 2022
Rise in Clinical Trials Powers Growth of Cloud-based Drug Discovery Platforms
EXHIBIT: Total Number of Registered Clinical Studies in'000s Worldwide (2012-2024)
Adoption of Advanced Technologies in Cloud-Based Drug Discovery Propels Market Growth
Adoption of Advanced Technologies in Cloud-Based Drug Discovery Propels Market Growth
The Transformative Impact of AI and Machine Learning in Drug Discovery
The Advantages of Cloud Adoption for Pharmaceutical Manufacturers
Precision Medicine Meets Artificial Intelligence: Revolutionizing Drug Discovery for a Personalized Future
Optimizing Cloud Costs for the Pharmaceutical Industry with Data Platforms
The Role of Hybrid Cloud Platforms in Advancing Drug Discovery and Life Sciences
Cloud Security Challenges in Cloud-Based Drug Discovery for the Pharmaceutical Industry
Enhancing Collaborative Research in Cloud-Based Drug Discovery with AI and Cloud Technologies
The Rising Adoption of Cloud-Based Drug Discovery Platforms in Emerging Markets
In-Silico Drug Discovery Gears Up to Eureka Moment with Cloud-based Platforms
Demand for Cloud-based Drug Discovery Platforms from CROs Set to Increase Rapidly
EXHIBIT: Global Contract Research Outsourcing Market Revenues (US$ Million) by Geographic Region/Country for 2020 and 2027
4. GLOBAL MARKET PERSPECTIVE
World Cloud-Based Drug Discovery Platforms Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
World Recent Past, Current & Future Analysis for Cloud-Based Drug Discovery Platforms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
World Historic Review for Cloud-Based Drug Discovery Platforms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
World 16-Year Perspective for Cloud-Based Drug Discovery Platforms by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
World Recent Past, Current & Future Analysis for Pharmaceutical Vendors End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
World Historic Review for Pharmaceutical Vendors End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
World 16-Year Perspective for Pharmaceutical Vendors End-Use by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
World Recent Past, Current & Future Analysis for Biotech Vendors End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
World Historic Review for Biotech Vendors End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
World 16-Year Perspective for Biotech Vendors End-Use by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
World Recent Past, Current & Future Analysis for Contract Research Organizations End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
World Historic Review for Contract Research Organizations End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
World 16-Year Perspective for Contract Research Organizations End-Use by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
UNITED STATES
Cloud-Based Drug Discovery Platforms Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
USA Recent Past, Current & Future Analysis for Cloud-Based Drug Discovery Platforms by End-Use - Pharmaceutical Vendors End-Use, Biotech Vendors End-Use, Contract Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
USA Historic Review for Cloud-Based Drug Discovery Platforms by End-Use - Pharmaceutical Vendors End-Use, Biotech Vendors End-Use, Contract Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
USA 16-Year Perspective for Cloud-Based Drug Discovery Platforms by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical Vendors End-Use, Biotech Vendors End-Use, Contract Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
CANADA
Canada Recent Past, Current & Future Analysis for Cloud-Based Drug Discovery Platforms by End-Use - Pharmaceutical Vendors End-Use, Biotech Vendors End-Use, Contract Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
Canada Historic Review for Cloud-Based Drug Discovery Platforms by End-Use - Pharmaceutical Vendors End-Use, Biotech Vendors End-Use, Contract Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
Canada 16-Year Perspective for Cloud-Based Drug Discovery Platforms by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical Vendors End-Use, Biotech Vendors End-Use, Contract Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
JAPAN
Cloud-Based Drug Discovery Platforms Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
Japan Recent Past, Current & Future Analysis for Cloud-Based Drug Discovery Platforms by End-Use - Pharmaceutical Vendors End-Use, Biotech Vendors End-Use, Contract Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
Japan Historic Review for Cloud-Based Drug Discovery Platforms by End-Use - Pharmaceutical Vendors End-Use, Biotech Vendors End-Use, Contract Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
Japan 16-Year Perspective for Cloud-Based Drug Discovery Platforms by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical Vendors End-Use, Biotech Vendors End-Use, Contract Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
CHINA
Cloud-Based Drug Discovery Platforms Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
China Recent Past, Current & Future Analysis for Cloud-Based Drug Discovery Platforms by End-Use - Pharmaceutical Vendors End-Use, Biotech Vendors End-Use, Contract Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
China Historic Review for Cloud-Based Drug Discovery Platforms by End-Use - Pharmaceutical Vendors End-Use, Biotech Vendors End-Use, Contract Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
China 16-Year Perspective for Cloud-Based Drug Discovery Platforms by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical Vendors End-Use, Biotech Vendors End-Use, Contract Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
EUROPE
Cloud-Based Drug Discovery Platforms Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
Europe Recent Past, Current & Future Analysis for Cloud-Based Drug Discovery Platforms by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
Europe Historic Review for Cloud-Based Drug Discovery Platforms by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
Europe 16-Year Perspective for Cloud-Based Drug Discovery Platforms by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
Europe Recent Past, Current & Future Analysis for Cloud-Based Drug Discovery Platforms by End-Use - Pharmaceutical Vendors End-Use, Biotech Vendors End-Use, Contract Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
Europe Historic Review for Cloud-Based Drug Discovery Platforms by End-Use - Pharmaceutical Vendors End-Use, Biotech Vendors End-Use, Contract Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
Europe 16-Year Perspective for Cloud-Based Drug Discovery Platforms by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical Vendors End-Use, Biotech Vendors End-Use, Contract Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
FRANCE
Cloud-Based Drug Discovery Platforms Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
France Recent Past, Current & Future Analysis for Cloud-Based Drug Discovery Platforms by End-Use - Pharmaceutical Vendors End-Use, Biotech Vendors End-Use, Contract Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
France Historic Review for Cloud-Based Drug Discovery Platforms by End-Use - Pharmaceutical Vendors End-Use, Biotech Vendors End-Use, Contract Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
France 16-Year Perspective for Cloud-Based Drug Discovery Platforms by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical Vendors End-Use, Biotech Vendors End-Use, Contract Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
GERMANY
Cloud-Based Drug Discovery Platforms Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
Germany Recent Past, Current & Future Analysis for Cloud-Based Drug Discovery Platforms by End-Use - Pharmaceutical Vendors End-Use, Biotech Vendors End-Use, Contract Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
Germany Historic Review for Cloud-Based Drug Discovery Platforms by End-Use - Pharmaceutical Vendors End-Use, Biotech Vendors End-Use, Contract Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
Germany 16-Year Perspective for Cloud-Based Drug Discovery Platforms by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical Vendors End-Use, Biotech Vendors End-Use, Contract Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
ITALY
Italy Recent Past, Current & Future Analysis for Cloud-Based Drug Discovery Platforms by End-Use - Pharmaceutical Vendors End-Use, Biotech Vendors End-Use, Contract Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
Italy Historic Review for Cloud-Based Drug Discovery Platforms by End-Use - Pharmaceutical Vendors End-Use, Biotech Vendors End-Use, Contract Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
Italy 16-Year Perspective for Cloud-Based Drug Discovery Platforms by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical Vendors End-Use, Biotech Vendors End-Use, Contract Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
UNITED KINGDOM
Cloud-Based Drug Discovery Platforms Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
UK Recent Past, Current & Future Analysis for Cloud-Based Drug Discovery Platforms by End-Use - Pharmaceutical Vendors End-Use, Biotech Vendors End-Use, Contract Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
UK Historic Review for Cloud-Based Drug Discovery Platforms by End-Use - Pharmaceutical Vendors End-Use, Biotech Vendors End-Use, Contract Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
UK 16-Year Perspective for Cloud-Based Drug Discovery Platforms by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical Vendors End-Use, Biotech Vendors End-Use, Contract Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
REST OF EUROPE
Rest of Europe Recent Past, Current & Future Analysis for Cloud-Based Drug Discovery Platforms by End-Use - Pharmaceutical Vendors End-Use, Biotech Vendors End-Use, Contract Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
Rest of Europe Historic Review for Cloud-Based Drug Discovery Platforms by End-Use - Pharmaceutical Vendors End-Use, Biotech Vendors End-Use, Contract Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
Rest of Europe 16-Year Perspective for Cloud-Based Drug Discovery Platforms by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical Vendors End-Use, Biotech Vendors End-Use, Contract Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Cloud-Based Drug Discovery Platforms Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
Asia-Pacific Recent Past, Current & Future Analysis for Cloud-Based Drug Discovery Platforms by End-Use - Pharmaceutical Vendors End-Use, Biotech Vendors End-Use, Contract Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
Asia-Pacific Historic Review for Cloud-Based Drug Discovery Platforms by End-Use - Pharmaceutical Vendors End-Use, Biotech Vendors End-Use, Contract Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
Asia-Pacific 16-Year Perspective for Cloud-Based Drug Discovery Platforms by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical Vendors End-Use, Biotech Vendors End-Use, Contract Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030
REST OF WORLD
Rest of World Recent Past, Current & Future Analysis for Cloud-Based Drug Discovery Platforms by End-Use - Pharmaceutical Vendors End-Use, Biotech Vendors End-Use, Contract Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
Rest of World Historic Review for Cloud-Based Drug Discovery Platforms by End-Use - Pharmaceutical Vendors End-Use, Biotech Vendors End-Use, Contract Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2014 through 2022 and % CAGR
Rest of World 16-Year Perspective for Cloud-Based Drug Discovery Platforms by End-Use - Percentage Breakdown of Value Revenues for Pharmaceutical Vendors End-Use, Biotech Vendors End-Use, Contract Research Organizations End-Use and Other End-Uses for the Years 2014, 2024 & 2030

COMPETITIVE METRICS

COMPETITORS (ALPHABETICAL)

%

VALIDATED RESEARCH *

* Login to Participate & View Data Stacks
* Participating executives must be from a competitive company. Executive credentials are validated by a one-time two-factor authentication, in compliance with GDPR guidelines. Verified executives have complimentary access to our proprietary MarketGlassTM platform and relevant data silos including Trend Data; Brand/IP/TM Feeds; and Market Size, Share & Rank Clusters. Qualified influencers are also invited to join our Expert Panels. Privileges include purchase credits, and collaborative bespoke builds.
View All Companies...

PARTICIPATE NOW!

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com

[chatbot]